Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Specialty Chemicals

Clean Science and Technology Limited, research, develops, manufactures, and markets specialty chemicals in India and internationally. The company operates through Performance Chemicals, FMCG Chemicals, and Pharma & Agro Intermediates segments. It also offers FMCG Chemicals, including anisole, guaiacol, 4-methoxy acetophenone, butylated hydroxy anisole, veratrole, L-ascorbyl palmitate, tertiary butyl hydroquinone, ortho methoxy toluene, and para di-methoxy benzene (1,4-DMB). In addition, the company offers performance chemicals comprising clean light stab 770, 4-hydroxy tempo, mono methyl ether of hydroquinone, butylated hydroxy anisole, L-ascorbyl palmitate, 2,5-di-tertiary butyl hydroquinone, tertiary butyl hydroquinone, and dimethyl sebacate. Further, it provides pharma and agro intermediates, such as dicyclohexylcarbodimide, veratrole, para benzoquinone, and para di-methoxy benzene (1,4-DMB). Clean Science and Technology Limited serves food and infant food formulations, agricultural chemicals, polymers and monomers, perfumes, cosmetic, and other sectors. The company was incorporated in 2003 and is based in Pune, India.

Revenue projections:

Revenue projections for CLEAN
Revenue projections for CLEAN

CLEAN's revenue is forecasted to dip below last year's figures, raising concerns for investors who are typically wary of declining financial performance. Such drops can directly affect the company's bottom line, potentially leading to a decrease in overall profitability, making investors more cautious in their decisions.

Financial Ratios:

currentRatio 5.011000
forwardPE 23.340117
debtToEquity 0.135000
earningsGrowth -0.214000
revenueGrowth -0.055000
grossMargins 0.626530
operatingMargins 0.300670
trailingEps 21.580000
forwardEps 33.365300

A current ratio of 5.011 for CLEAN implies that the company has ample liquidity to meet its short-term debts. CLEAN's cash reserves and current assets should easily cover these obligations, highlighting its financial stability and ability to manage short-term liabilities.
CLEAN's Forward PE is in a favorable range, suggesting the stock is reasonably priced relative to its earnings. This indicates the stock is not overpriced, providing room for potential growth and making it an attractive option for investors looking for solid value and future upside.
CLEAN's low earnings and revenue growth suggest shrinking profits are likely. This could reflect broader financial struggles, signaling that the company might face difficulties in sustaining its profitability.
Positive gross and operating margins for Clean Science and Technology Limited suggest that the company is operating profitably. These margins highlight Clean Science and Technology Limited's efficiency in managing costs while maintaining healthy revenue streams, contributing to its overall financial strength.
CLEAN's forward EPS being higher than its trailing EPS points to expected growth in profitability. This suggests that the company is projected to perform better in the current financial year, with higher earnings forecasted compared to the previous year.

Price projections:

Price projections for CLEAN
Price projections for CLEAN

CLEAN's stock price has consistently been near the lower edge of expected values, indicating potential struggles in meeting growth projections. This trend may reflect a cautious market sentiment toward the company.

Recommendation changes over time:

Recommendations trend for CLEAN
Recommendations trend for CLEAN


Analysts' buy bias for Clean Science and Technology Limited signals that the stock is considered a favorable investment. This outlook might prompt investors to allocate funds to Clean Science and Technology Limited, seeing it as a solid and profitable choice to park their money and potentially benefit from the company's long-term growth.